Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Lenarczyk

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Medical Law Review|May 3, 2026
The promise of the EU's draft repurposing programmeGabriela Lenarczyk, Johnathon Liddicoat
IIC; International Review of Industrial Property and Copyright Law|May 22, 2023
Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?Żaneta Zemła-Pacud, Gabriela Lenarczyk
Journal of Law and the Biosciences|November 12, 2025
The future of AI regulation in drug development: a comparative analysisGabriela Lenarczyk, Timo Minssen, Nicholson Price, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Medical Law Review|May 3, 2026
The promise of the EU's draft repurposing programmeGabriela Lenarczyk, Johnathon Liddicoat
IIC; International Review of Industrial Property and Copyright Law|May 22, 2023
Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?Żaneta Zemła-Pacud, Gabriela Lenarczyk
Journal of Law and the Biosciences|November 12, 2025
The future of AI regulation in drug development: a comparative analysisGabriela Lenarczyk, Timo Minssen, Nicholson Price, et al.
Pageof 1